GGrantIndex
Sort

46,585 grants matching heart failure

A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

$680,132
Connie Meeyoung Rhee · University Of California-Irvine · R01 · FY2021 · DK

A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

$680,132
Connie Meeyoung Rhee · University Of California-Irvine · R01 · FY2022 · DK

CoPARC: Colorado Pulmonary Alcohol Research Collaborative

$680,119
Ellen L Burnham · University Of Colorado Denver · R24 · FY2021 · AA

Systemically restricted 5-HT2B antagonists for pulmonary arterial hypertension

$680,115
William D Merryman · Vanderbilt University · R01 · FY2025 · HL

In-home wearable system to detect early-stage decompensation in heart failure patients

$680,070
Yeonsik Noh · University Of Massachusetts Amherst · R01 · FY2025 · HL

Risk Stratification in MADIT II Type Patients

$680,027
University Of Rochester · R01 · FY2005 · HL

Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH

$679,977
You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2022 · HL

Graves' Disease Therapy Risks to Mother and Fetus

$679,971
Scott A. Rivkees · Yale University · R01 · FY2011 · HD

The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia

$679,950
Vassilios James Bezzerides · Boston Children'S Hospital · R01 · FY2023 · HL

Sedentary behavior, physical activity, sleep, and cardiovascular risk in pregnancy: the Pregnancy 24/7 cohort study

$679,917
Kara Marie Whitaker · University Of Iowa · R01 · FY2021 · HL

Sedentary behavior, physical activity, sleep, and cardiovascular risk in pregnancy: the Pregnancy 24/7 cohort study

$679,917
Kara Marie Whitaker · University Of Iowa · R01 · FY2022 · HL

Assessing the relationship between extreme heat and cardiovascular and pulmonary outcomes to identify strategies for health system intervention

$679,906
Melissa Poulsen · Geisinger Clinic · R01 · FY2025 · HL

IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia

$679,894
Meredith Hay · University Of Arizona · U01 · FY2023 · AG

Role of Kir4.1 in regulating NCC and ROMK in DCT

$679,882
Wen-Hui Wang · New York Medical College · R01 · FY2022 · DK

Psycho-neuro-immune Mechanisms Linking Stigma and Discrimination to Carotid Plaque Formation in Persons living with HIV

$679,834
Roger Christopher McIntosh · University Of Miami Coral Gables · R01 · FY2025 · HL

Dynamic changes of the Nav1.5 interactome and contributions to heart failure

$679,651
Geoffrey S Pitt · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · HL

Dynamic changes of the Nav1.5 interactome and contributions to heart failure

$679,651
Geoffrey S Pitt · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · HL

Adipose Dysfunction, Imaging, Physiology, and Outcomes with SGLT2i's for Sleep Apnea: The ADIPOSA Study

$679,601
Ian Jason Neeland · Case Western Reserve University · R01 · FY2024 · HL

Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension

$679,575
You-Yang Zhao · University Of Illinois At Chicago · R01 · FY2016 · HL

Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension

$679,575
You-Yang Zhao · University Of Illinois At Chicago · R01 · FY2017 · HL

Effectiveness of Gastric Sleeve vs. Gastric Bypass for Cardiovascular Disease

$679,565
Karen Jacqueline Coleman · Kaiser Foundation Research Institute · R01 · FY2017 · HL

Acute declines in kidney function during blood pressure interventions in CKD

$679,559
Elaine Ku · University Of California, San Francisco · R01 · FY2023 · DK

ARIC Neurocognitive Study (ARIC-NCS)

$679,502
Alvaro Alonso · University Of Minnesota · U01 · FY2012 · HL

Racial/Ethnic Disparities in Heart Failure: A Cross Cohort Collaboration

$679,452
Charles B Eaton · Kent County Memorial Hospital · R01 · FY2023 · HL

Dietary iron requirements in US adults

$679,387
Stephen R. Hennigar · Lsu Pennington Biomedical Research Ctr · R01 · FY2025 · HD